{
    "2021-01-29": [
        [
            {
                "time": "2021-01-29",
                "orginal_text": "晨会聚焦210129重点关注哔哩哔哩、拉卡拉、华测检测、泰格医药、连城数控",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "晨会聚焦",
                        "重点公司"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "orginal_text": "【天风医药】泰格医药：2020年实现快速增长，2021年有望更进一步",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "快速增长",
                        "2021展望"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-15",
                "orginal_text": "【权益变动】泰格医药(03347-HK)被NINETONEUKLIMITED减持12.18万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "权益变动",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-10",
                "orginal_text": "医药生物行业：药品集采常态化 坚定拥抱医药创新",
                "features": {
                    "keywords": [
                        "药品集采",
                        "医药创新"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-20",
                "orginal_text": "泰格医药（300347）2020年业绩预告点评：主营业务持续恢复，非经常性收益较高",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "业绩预告",
                        "主营业务恢复"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}